Dare Bioscience annual revenue
2012
2013
2014
2016
2021
2022
2023
2024
2025
Dare Bioscience Revenue Growth & History (DARE)
Dare Bioscience reported $1.0M in revenue for fiscal 2025, an increase of 10429.36% from the previous fiscal year.
View full Dare Bioscience company overviewDare Bioscience annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.0M | $1.0M | +10429.36% |
| 2024 | 2024-12-31 | $9,784 | −$2.8M | −99.65% |
| 2023 | 2023-12-31 | $2.8M | −$7.2M | −71.92% |
| 2022 | 2022-12-31 | $10.0M | $10.0M | — |
| 2021 | 2021-12-31 | $0 | — | — |
| 2016 | 2016-12-31 | $766,000 | — | — |
| 2014 | 2014-12-31 | $80,000 | $74,000 | +1233.33% |
| 2013 | 2013-12-31 | $6,000 | −$619,000 | −99.04% |
| 2012 | 2012-12-31 | $625,000 | — | — |
Dare Bioscience quarterly revenue
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q4.16
Q1.17
Q2.17
Q2.21
Q3.21
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $187,546 | $208,718 | +985.82% |
| Q1 2026 | 2026-03-31 | $152,455 | $127,028 | +499.58% |
| Q4 2025 | 2025-12-31 | $1.0M | $1.1M | +1708.36% |
| Q3 2025 | 2025-09-30 | $2,262 | −$39,429 | −94.57% |
| Q2 2025 | 2025-06-30 | −$21,172 | −$43,610 | −194.36% |
| Q1 2025 | 2025-03-31 | $25,427 | $16,125 | +173.35% |
| Q4 2024 | 2024-12-31 | −$63,647 | −$1.9M | −103.52% |
| Q3 2024 | 2024-09-30 | $41,691 | −$958,309 | −95.83% |
| Q2 2024 | 2024-06-30 | $22,438 | $22,438 | — |
| Q1 2024 | 2024-03-31 | $9,302 | $9,302 | — |
| Q4 2023 | 2023-12-31 | $1.8M | — | — |
| Q3 2023 | 2023-09-30 | $1.0M | $1.0M | — |
| Q2 2023 | 2023-06-30 | $0 | −$10.0M | −100.00% |
| Q1 2023 | 2023-03-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $10.0M | $10.0M | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q2 2017 | 2017-06-30 | $642,000 | — | — |
| Q1 2017 | 2017-03-31 | $1.2M | — | — |
| Q4 2016 | 2016-12-31 | $766,000 | — | — |
| Q1 2015 | 2015-03-31 | $0 | −$47,000 | −100.00% |
| Q4 2014 | 2014-12-31 | $0 | −$6,000 | −100.00% |
| Q3 2014 | 2014-09-30 | $0 | — | — |
| Q2 2014 | 2014-06-30 | $33,000 | — | — |
| Q1 2014 | 2014-03-31 | $47,000 | — | — |
| Q4 2013 | 2013-12-31 | $6,000 | — | — |
Dare Bioscience revenue growth trends
Dare Bioscience's latest reported quarter, Q2 2026, generated $187,546 in revenue, an increase of 985.82% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Dare Bioscience source filings ↗